Health & Pharmaceuticals
We advise laboratories at every stage where a patent can affect a product's access to market. We analyze the validity and scope of patents and applications, prepare third-party observations and office-action responses before the INPI, assess freedom to operate ahead of a launch, and represent our clients in nullity and infringement litigation, including interim injunctions. We pay particular attention to applications covering crystalline forms, salts, combinations, dosages and new uses, where the patentability analysis requires familiarity with both local examination guidelines and comparative practice. We integrate this work with regulatory strategy before ANMAT, since in the pharmaceutical sector patent terms and marketing-authorization timelines condition one another.